Reding Andrew P. 4
4 · Precision Therapeutics Inc. · Filed Jan 10, 2019
Insider Transaction Report
Form 4
Reding Andrew P.
Director
Transactions
- Award
Stock Option (right to buy)
2018-12-31+24,229→ 24,229 totalExercise: $0.62From: 2018-12-31Exp: 2028-12-31→ Common Stock (24,229 underlying)
Holdings
- 53
Common Stock, $.01 par value